CXCR2 has a significant positive correlation with most immune cells, and the activity of most immune response pathways, including acute inflammatory reactions, is increased, suggesting that CXCR2 can inhibit cancer by inducing immune responses, and significant down-regulation of tumor tissues is also the main reason for worse prognosis. This evidence concerns the gene CXCR2 and cancer.